Multiple sclerosis: open trials in Netherlands

16 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Zuyderland Medisch Centrum Stichting, Geleen
Registry updated 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
Zuyderland Medisch Centrum Stichting, Heerlen
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Albert Schweitzer Ziekenhuis, Dordrecht · Zuyderland Medisch Centrum Stichting, Geleen
Registry updated 2026-10-27
NCT05054140
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
Trial Treatment · Phase 2 · Immunic AG
Amsterdam UMC Stichting, Amsterdam · Alrijne Ziekenhuis Leiden Poli Neurologie, t.a.v. C. Holthuijsen, Leiden
Registry updated 2026-10-23
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Amsterdam · Novartis Investigative Site, Arnhem · Novartis Investigative Site, Leiden · Novartis Investigative Site, 's-Hertogenbosch · Novartis Investigative Site, Sittard-Geleen
Registry updated 2026-10-13
2025-522922-11-00
A trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis
Trial Treatment · Phase 2 · Idorsia Pharmaceuticals Ltd.
Centre for Human Drug Research, Leiden
Registry updated 2026-09-14
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Amsterdam UMC Stichting, Amsterdam · Rijnstate Ziekenhuis Stichting, Arnhem · Zuyderland Medisch Centrum Stichting, Geleen · Alrijne Zorggroep Stichting, Leiderdorp · Jeroen Bosch Ziekenhuis Stichting, 'S-Hertogenbosch
Registry updated 2026-07-30
2026-525260-18-00
Use of Indipamide to reduce progression of disability in people with primary and secondary progressive multiple sclerosis (MS).
Trial Treatment · Phase 2 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-07-08
NCT06782724
Psilocybin Therapy for Psychological Distress in Palliative Patients
Trial Treatment · Phase 2 · University Medical Center Groningen
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-05-08
NCT07225868
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
Trial Treatment · Universiteit Leiden
Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University, Leiden
Registry updated 2025-11-10
NCT06068582
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
Trial Treatment · Amsterdam UMC, location VUmc
Amsterdam University Medical Centers, location VUmc, Amsterdam
Registry updated 2025-04-03
NCT06016309
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
Research · University Medical Center Groningen
University Medical Center Groningen (UMCG), Groningen
Registry updated 2025-03-30
NCT06827834
Spinal Cord Monitoring in Multiple Sclerosis
Research · Zuyderland Medisch Centrum
Rijnstate, Arnhem · Albert Schweitzer Ziekenhuis, Dordrecht · Zuyderland Medisch Centrum, Geleen · Erasmus MC, Rotterdam · Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Registry updated 2025-02-14
NCT06627465
Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis
Research · Amsterdam UMC, location VUmc
Amsterdam UMC, Amsterdam · Rijnstate Arnhem, Arnhem · Zuyderland Medical Center, Geleen
Registry updated 2024-10-04
NCT06567197
Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
Research · Amsterdam UMC, location VUmc
Amsterdam UMC, Amsterdam · St. Antonius Hospital, Nieuwegein
Registry updated 2024-08-22
NCT05834855
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Trial Treatment · Phase 3 · Amsterdam UMC, location VUmc
Amsterdam UMC location VUmc, Amsterdam
Registry updated 2023-04-28

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error